Viewing Study NCT02041351


Ignite Creation Date: 2025-12-24 @ 11:45 PM
Ignite Modification Date: 2025-12-25 @ 9:38 PM
Study NCT ID: NCT02041351
Status: COMPLETED
Last Update Posted: 2016-01-27
First Post: 2014-01-18
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Biweekly Docetaxel in Patients With Metastatic Breast Cancer.
Sponsor: Centro Universitario contra el Cáncer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module